Statement: Zantac (ranitidine) litigation – Delaware State Court Daubert Ruling - GSK

Retrieved on: 2024-06-01 15:27:35

Tags for this article:

Click the tags to see associated articles and topics

Statement: Zantac (ranitidine) litigation – Delaware State Court Daubert Ruling - GSK. View article details on hiswai:

Summary

The article discusses GSK's challenge to a Delaware Court ruling allowing cancer claims linked to ranitidine under the Daubert standard, despite epidemiological studies showing no consistent evidence. This involves issues in U.S. evidence law as related to GSK plc.

Article found on: www.gsk.com

View Original Article